Report Detail
Global (United States, European Union and China) Drugs for Melanoma Market Research Report 2019-2025
- RnM3665346 |
- 13 August, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Melanoma is the type of cancer, in which the normal melanin-producing cells called melanocytes are turned into cancerous cells. Melanoma is usually, but not always cancer of the skin and is the most dangerous type of cancer. Mutation in melanin-producing melanocytes leads to uncontrolled division of cells forming the malignant tumor. Mainly there are three general categories of melanoma as Cutaneous, mucosal and ocular. Cutaneous melanoma is melanoma of the skin and is most common because most pigment cells are found in the skin. Mucosal melanoma is melanoma of mucous membrane of the body, including the mouth, the nasal passages, the throat, the vagina or the anus. The rare ocular melanoma or uveal melanoma occurs in the eye.
In 2019, the market size of Drugs for Melanoma is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Drugs for Melanoma.
This report studies the global market size of Drugs for Melanoma, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Drugs for Melanoma sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Amgen
Bristol-Myers Squibb
Roche
Genentech
Janssen Biotech
Novartis
Pfizer
Sanofi
Takeda Pharma
Teva Pharma
Market Segment by Product Type
Chemotherapy
Immunotherapy
Targeted Therapy
Market Segment by Application
Hospitals
Clinics
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Drugs for Melanoma status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Drugs for Melanoma manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Drugs for Melanoma are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Drugs for Melanoma Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Chemotherapy
- 1.3.3 Immunotherapy
- 1.3.4 Targeted Therapy
- 1.4 Market Segment by Application
- 1.4.1 Global Drugs for Melanoma Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Clinics
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Drugs for Melanoma Market Size
- 2.1.1 Global Drugs for Melanoma Revenue 2014-2025
- 2.1.2 Global Drugs for Melanoma Sales 2014-2025
- 2.2 Drugs for Melanoma Growth Rate by Regions
- 2.2.1 Global Drugs for Melanoma Sales by Regions 2014-2019
- 2.2.2 Global Drugs for Melanoma Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Drugs for Melanoma Sales by Manufacturers
- 3.1.1 Drugs for Melanoma Sales by Manufacturers 2014-2019
- 3.1.2 Drugs for Melanoma Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Drugs for Melanoma Revenue by Manufacturers (2014-2019)
- 3.2.2 Drugs for Melanoma Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Drugs for Melanoma Market Concentration Ratio (CR5 and HHI)
- 3.3 Drugs for Melanoma Price by Manufacturers
- 3.4 Key Manufacturers Drugs for Melanoma Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Drugs for Melanoma Market
- 3.6 Key Manufacturers Drugs for Melanoma Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Chemotherapy Sales and Revenue (2014-2019)
- 4.1.2 Immunotherapy Sales and Revenue (2014-2019)
- 4.1.3 Targeted Therapy Sales and Revenue (2014-2019)
- 4.2 Global Drugs for Melanoma Sales Market Share by Type
- 4.3 Global Drugs for Melanoma Revenue Market Share by Type
- 4.4 Drugs for Melanoma Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Drugs for Melanoma Sales by Application
6 United States
- 6.1 United States Drugs for Melanoma Breakdown Data by Company
- 6.2 United States Drugs for Melanoma Breakdown Data by Type
- 6.3 United States Drugs for Melanoma Breakdown Data by Application
7 European Union
- 7.1 European Union Drugs for Melanoma Breakdown Data by Company
- 7.2 European Union Drugs for Melanoma Breakdown Data by Type
- 7.3 European Union Drugs for Melanoma Breakdown Data by Application
8 China
- 8.1 China Drugs for Melanoma Breakdown Data by Company
- 8.2 China Drugs for Melanoma Breakdown Data by Type
- 8.3 China Drugs for Melanoma Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Drugs for Melanoma Breakdown Data by Company
- 9.2 Rest of World Drugs for Melanoma Breakdown Data by Type
- 9.3 Rest of World Drugs for Melanoma Breakdown Data by Application
- 9.4 Rest of World Drugs for Melanoma Breakdown Data by Countries
- 9.4.1 Rest of World Drugs for Melanoma Sales by Countries
- 9.4.2 Rest of World Drugs for Melanoma Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Amgen
- 10.1.1 Amgen Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Drugs for Melanoma
- 10.1.4 Drugs for Melanoma Product Introduction
- 10.1.5 Amgen Recent Development
- 10.2 Bristol-Myers Squibb
- 10.2.1 Bristol-Myers Squibb Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Drugs for Melanoma
- 10.2.4 Drugs for Melanoma Product Introduction
- 10.2.5 Bristol-Myers Squibb Recent Development
- 10.3 Roche
- 10.3.1 Roche Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Drugs for Melanoma
- 10.3.4 Drugs for Melanoma Product Introduction
- 10.3.5 Roche Recent Development
- 10.4 Genentech
- 10.4.1 Genentech Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Drugs for Melanoma
- 10.4.4 Drugs for Melanoma Product Introduction
- 10.4.5 Genentech Recent Development
- 10.5 Janssen Biotech
- 10.5.1 Janssen Biotech Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Drugs for Melanoma
- 10.5.4 Drugs for Melanoma Product Introduction
- 10.5.5 Janssen Biotech Recent Development
- 10.6 Novartis
- 10.6.1 Novartis Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Drugs for Melanoma
- 10.6.4 Drugs for Melanoma Product Introduction
- 10.6.5 Novartis Recent Development
- 10.7 Pfizer
- 10.7.1 Pfizer Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Drugs for Melanoma
- 10.7.4 Drugs for Melanoma Product Introduction
- 10.7.5 Pfizer Recent Development
- 10.8 Sanofi
- 10.8.1 Sanofi Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Drugs for Melanoma
- 10.8.4 Drugs for Melanoma Product Introduction
- 10.8.5 Sanofi Recent Development
- 10.9 Takeda Pharma
- 10.9.1 Takeda Pharma Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Drugs for Melanoma
- 10.9.4 Drugs for Melanoma Product Introduction
- 10.9.5 Takeda Pharma Recent Development
- 10.10 Teva Pharma
- 10.10.1 Teva Pharma Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Drugs for Melanoma
- 10.10.4 Drugs for Melanoma Product Introduction
- 10.10.5 Teva Pharma Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Drugs for Melanoma Sales Channels
- 11.2.2 Drugs for Melanoma Distributors
- 11.3 Drugs for Melanoma Customers
12 Market Forecast
- 12.1 Global Drugs for Melanoma Sales and Revenue Forecast 2019-2025
- 12.2 Global Drugs for Melanoma Sales Forecast by Type
- 12.3 Global Drugs for Melanoma Sales Forecast by Application
- 12.4 Drugs for Melanoma Forecast by Regions
- 12.4.1 Global Drugs for Melanoma Sales Forecast by Regions 2019-2025
- 12.4.2 Global Drugs for Melanoma Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on DrugsforMelanoma. Industry analysis & Market Report on DrugsforMelanoma is a syndicated market report, published as Global (United States, European Union and China) Drugs for Melanoma Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of DrugsforMelanoma market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
